Liberia's HIV epidemic under the microscope: major study completed

NCT ID NCT03733093

Completed Knowledge-focused Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 6 times

Summary

This study followed 1,377 people living with HIV in Liberia over three years to track how the disease progresses and affects their health. Researchers collected blood and urine samples, conducted physical exams, and asked about medications and risk behaviors. The goal was to gather information to help improve HIV prevention and treatment programs in Liberia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide valuable data to improve HIV prevention and treatment strategies in Liberia.
What could go wrong: This is an observational study, not a treatment trial, so it will not directly benefit participants. Results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease sexually transmitted disease tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

C.H. Rennie Hospital

Kakata, Liberia
Duport Road Clinic

Paynesville, Liberia
John F. Kennedy (JFK) Medical Center

Monrovia, Liberia
Redemption Hospital

Monrovia, Liberia

More trials for these conditions

Other studies related to the condition(s) this trial covers.